Oculopharyngeal muscular dystrophy, other ocular myopathies, and progressive external ophthalmoplegia

Neuromuscular Disorders

Volumn 7, Issue SUPPL. 1, 1997, Pages

  Rowland, Lewis P ^a   Hirano, Michio ^a   DiMauro, Salvatore ^a   Schon, Eric A ^a  

^a NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Intranuclear inclusions; Mitochondrial diseases; Ocular ophthalmoplegia; Oculopharyngeal muscular dystrophy; Oculopharyngodistal dystrophy; Spinocerebellar degenerations

Indexed keywords

MITOCHONDRIAL DNA;

ATAXIA; AUTOSOMAL DOMINANT DISORDER; CONFERENCE PAPER; EXTERNAL OPHTHALMOPLEGIA; EXTRAOCULAR MUSCLE; HUMAN; MITOCHONDRIAL MYOPATHY; MOLECULAR GENETICS; MUSCULAR DYSTROPHY; ONSET AGE; POINT MUTATION; PRIORITY JOURNAL;

ADULT; AGE OF ONSET; CHILD; DIAGNOSIS, DIFFERENTIAL; DNA, MITOCHONDRIAL; HUMANS; MITOCHONDRIAL MYOPATHIES; MUSCULAR DYSTROPHIES; OCULOMOTOR MUSCLES; OPHTHALMOPLEGIA; PEDIGREE; PHARYNGEAL MUSCLES; SPINOCEREBELLAR DEGENERATIONS;

EID: 0030728962     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(97)00076-X     Document Type: Conference Paper

References (70)

1. Rowland LP. Progressive external ophthalmoplegia. Handb Clin Neurol 1975;22:177-202.
2. Rowland LP. Progressive external ophthalmoplegia. Handb Clin Neurol 1992;62:287-329.
3. Brais B, Kie Y-G, Sanson M. et al. The oculopharyngeal muscular dystrophy locus maps to the region of the cardiac a and b myosin heavy chain genes on chromosome 14q11.2-q13. Hum Mol Genet 1995;4:429-434.
4. Rosenberg R, Lovelace RE, Rowland LP. Progressive ophthalmoplegia. Arch Neurol 1968;9:361-376.
5. Gordon PE, Dickoff D, Rowland LP et al. Erroneous diagnosis corrected after 27 years. Not spinal muscular atrophy with progressive ophthalmoplegia but minicore disease. Arch Neurol 1996;53:1194-1196.
6. Bodensteiner JB. Congenital myopathies. Muscle Nerve 1994;17:131-144.
7. Fardeau M, Tome FMS. Congenital myopathies. In: Engel AG, Franzini-Armstrong C, editors. Myology. New York: McGraw Hill, 1994;1487-1532.
8. Swash M, Schwartz MS. Familial multicore disease with focal loss of cross-striations and ophthalmoplegia. J Neurol Sci 1981;52:1-10.
9. Van Wijngaarden GK, Bethlem J, Dingemans KP, Coers C, Telerman-Topet N, Gerard JM. Familial focal loss of cross striations. J Neurol 1973;216:163-172.
10. Bethlem J, Arts WF, Dingemans KP. Common origin of rods, cores, miniature cores, and focal loss of cross-striations. Arch Neurol 1978;35:555-566.
11. Sugie H, Hanson R, Rasmussen G, Verity MA. Congenital neuromuscular disease with type 1 fibre hypotrophy, ophthalmoplegia and myofibril degeneration. J Neurol Neurosurg Psychiatry 1982; 45:507-512.
12. Bender AN, Bender MB. Muscle fiber hypotrophy with intact neuromuscular junctions. A study of a patient with congenital neuromuscular disease and ophthalmoplegia. Neurology 1977;27:206-212.
13. Lacomis D, Kupsky WP, Kuban KK, Specht LA. Childhood onset oculopharyngeal muscular dystrophy. Pediatr Neurol 1991;7:382-384.
14. Amato AA, Jackson CE, Ridings LW, Barohn RJ. Childhood-onset oculopharyngeal myopathy with chronic intestinal pseudoobstruction. Muscle Nerve 1995; 18:842-847.
15. Engel AG. Myasthenic syndromes. In: Engel AG, Franzini-Armstrong C, editors. Myology. New York: McGraw Hill, 1994:1798-1834.
16. Rowland LP, Eskanazi AN. Myasthenia gravis with features resembling muscular dystrophy. Neurology 1956;6:667-671.
17. Engle EC, Marondel I, Houtman WA. et al. Congenital fibrosis of the extraocular muscles (autosomal dominant congenital external ophthalmoplegia): genetic homogeneity, linkage refinement, and physical mapping on chromosome 12. Am J Hum Genet 1995; 57:1086-1904.
18. Holt IJ, Harding AE, Morgan-Hughes JA. Deletions of mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988; 331:717-719.
19. Zeviani M, Moraes C, DiMauro S. et al. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 1988;38:1339-1346.
20. Lestienne P, Ponsot G. Kearns-Sayre syndrome with muscle mitochondrial DNA deletion. Lancet 1988;1:85.
21. Moraes CT, DiMauro S, Zeviani M. et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 1989;320:1293-1299.
22. Laforet P, Lombes A, Eymard B. et al. Chronic progressive external ophthalmoplegia with ragged red fibers; clinical, morphological and genetic investigations in 43 patients. Neuromusc Disord 1995; 5:399-413.
23. Moraes CT, Ciacci F, Silvestri G. et al. Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. Neuromusc Disord 1993;3:43-50.
24. Mariotti C, Savarese N, Suomalainen A. et al. Genotype to phenotype correlations in mitochondrial encephalomyopathies associated with the A3243G mutation of mitochondrial DNA. J Neurol 1995;242:304-312.
25. Zeviani M, Bresolin N, Gellera C. et al. Nucleus-driven multiple large-scale deletions of the human mitochondrial genome; a new autosomal dominant disease. Am J Hum Genet 1990;47:904-914.
26. Servidei S, Zeviani M, Manfredi G. et al. Dominantly inherited mitochondrial myopathy with multiple deletions of mitochondrial DNA. Neurology 1991;41:1053-1059.
27. Suomalainen A, Majaender A, Haita M. et al. Multiple deletions of mitochondrial DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia. J Clin Invest 1992;90:61-66.
28. Suomalainen A, Kaukonen J, Amati P. et al. An autosomal locus predisposing to deletions of mtDNA. Nature Genet 1995;9:146-151.
29. Cormier V, Rotiga A, Tardieu M, Colonna M, Saudubray JM, Munnich A. Autosomal dominant deletions of the mitochondrial genome in a case of progressive encephalomyopathy. Am J Hum Genet 1991;48:643-648.
30. Bohlega S, Tanji K, Santorelli FM, Hirano M, al-Jishhi A, DiMauro S. Multiple mitochondrial DNA deletions associated with autosomal recessive ophthalmoplegia and severe cardiomyopathy. Neurology 1997 (in press).
31. Hirano M, Silvestri G, Blake DM. et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 1994;44:721-727.
32. Kawai H, Akaike M, Yokoi K. et al. Mitochondrial encephalomyopathy with autosomal dominant inheritance; a clinical and genetic entity of mitochondrial diseases. Muscle Nerve 1995; 18:753-760.
33. Zeviani M, Tiranti V. Inherited Mendelian defects. In: DiMauro S, Wallace DC, editors. Mitochondrial DNA in Human Pathology. New York: Raven Press, 1993;85-95.
34. Fabrizi GM, Tiranti V, Mariotti C. et al. Sequence analysis of mitochondrial DNA in a new maternally inherited encephalomyopathy. J Neural 1995;242:490-496.
35. Nakagawa M, Kaminishi Y, Isasahiki Y. et al. Familial mitochondrial encephalomyopathy with deaf-mutism, ophthalmoplegia, and leukodystrophy. Acta Neurol Scand 1995;92:102-108.
36. Ohno K, Tanaka M, Sahashi K. et al. Mitochondrial DNA deletions in inherited recurrent myoglobinuria. Ann Neurol 1991;29:364-369.
37. Mizusawa H, Watanabe M, Kanazawa I et al. Familial mitochondrial myopathy associated with peripheral neuropathy; partial deficiencies of complex I and complex IV. J Neurol Sci 1988;86:171-184.
38. Yusaki M, Ohkoshi N, Kanazawa I, Kagawa Y, Ohta S. Multiple deletions in mitochondrial DNA at direct repeats of non-d-loop regions in cases of familial mitochondrial myopathy. Biochem Biophys Res Commun 1989;164:1352-1357.
39. Cormier V, Rotig A, Tardieu M, Colonna M, Saudubray JM, Munnich A. Autosomal dominant deletions of the mitochondrial genome in a case of progressive encephalomyopathy. Am J Hum Genet 1991;48:643-648.
40. Takei Y, Ikeda S, Yanagisawa N, Takahashi W, Sekiguchi M, Hayashi T. Multiple mitochondrial DNA deletions in a patient with mitochondrial myopathy and cardiomyopathy but no ophthalmoplegia. Muscle Nerve 1995;18:1321-1325.
41. Griggs RC, Askanas V, DiMauro S. et al. Inclusion body myositis and myopathies. Ann Neurol 1995;38:705-713.
42. Johnston W, Karpati G, Carpenter S, Arnold D, Shoubridge EA. Late-onset mitochondrial myopathy. Ann Neurol 1995;37:16-23.
43. Barren TG, Bundey S, Macleod AF. Neurodegeneration and diabetes; UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet 1995;346:1458-1463.
44. Fassati A, Bordoni A, Amboni P. et al. Chronic PEO: correlative study of quantitative molecular data and histochemical and biochemical profile. J Neurol Sci 1994;123:140-146.
45. Taylor EW. Progressive vagus-glossopharyngeal paralysis with ptosis. A contribution to the group of family diseases. J Nerv Ment Dis 1915;42:129-139.
46. Amyot R. Hereditary, familial and acquired ptosis of late onset. Can Med Assoc J 1948;59:434-438.
47. Barbeau A. The syndrome of hereditary late onset ptosis and dysphagia in French Canada. In: Kuhn E, editor. Progressive Muskeldystrophic. Myotonie. Myasthenie. Berlin: Springer-Verlag, 1966:102-109.
48. Victor M, Hayes R, Adams RD. Oculopharyngeal muscular dystrophy with ptosis and dysphagia. N Engl J Med 1962;267:1267-1272.
49. Brais B, Rouleau GA, Sanson M, Gosselin F, Bouchard JP. OPMD revisited; diagnostic criteria and variability in phenotype. Neurology 1993;43:A201.
50. Tome FMS, Fardeau M. Nuclear inclusions in oculopharyngeal dystrophy. Acta Neuropathol 1980;49:85-87.
51. Tome FMS, Fardeau M. Oculopharyngeal muscular dystrophy. In: Engel AG, Franzini-Armstrong C, editors. Myology. New York: McGraw-Hill, 1994;2:1233-1245.
52. Bouchard JP, Gagne F, Tomé FMS, Brunet D. Nuclear inclusions in OPMD in Quebec. Can J Neurol Sci 1989; 16:446-450.
53. Blumen SC, Nisipeanu P, Sadeh M, Asherov A, Tomé FMS, Korczyn AD. Clinical features of oculopharyngeal muscular dystrophy among Bukhara Jews. Neuromusc Disord 1993;3:575-577.
54. Scrimgeour EM, Mastaglia FL. Oculopharyngeal and distal myopathy. Case study from Papua New Guinea. Am J Med Genet 1984;17:763-771.
55. Hardiman O, Halperin JJ, Farrell MA, Shapiro BE, Wray SH, Brown RH Jr. Neuropathic findings in oculopharyngeal muscular dystrophy. Report of seven cases and review of literature. Arch Neurol 1993;50:481-488.
56. Little BW, Perl DP. Oculopharyngeal muscular dystrophy. An autopsied case from the French-Canadian kindred. J Neurol Sci 1982;53:145-158.
57. Fried K, Arlozorov A, Spira R. Autosomal recessive oculopharyngeal muscular dystrophy. J Med Genet 1975;12:416-418.
58. Schroder JM, Krabbe B, Weis J. Oculopharyngeal muscular dystrophy: clinical and morphological follow-up study reveals mitochondrial alterations and unique nuclear inclusions in severe autosomal recessive type. Neuropathol Appl Neurobiol 1995;21:68-73.
59. Schotland DL, Rowland LP. Muscular dystrophy; features of ocular myopathy, distal myopathy, and myotonic dystrophy. Arch Neurol Psychiatry 1964;10:433-445.
60. Satoyoshi E, Murakami K, Kowa H. et al. Distal involvement of the extremities in ocular myopathy. Am J Ophthalmol 1965;59:669-673.
61. Satoyoshi E, Kinoshita M. Oculopharyngeal myopathy - report of four families. Arch Neurol 1977;34:89-92.
62. Fukuhara N, Kumamoto T, Tsubaki T, Mayuzumi T, Nita H. Oculopharyngeal muscular dystrophy and distal myopathy. Intrafamilial difference in the onset and distribution of muscular involvement. Acta Neurol Scand 1982;65:467-468.
63. Vita G, Dattola R, Santoro M, Messina C. Familial oculopharyngeal muscular dystrophy with distal spread. J Neurol 1983;230:57-64.
64. Komachi H, Okeda R, Ishii N, Yangisawa K, Yamada M, Miyatake T. Motor neuron disease with dementia and ophthalmoplegia. Clinical and pathological study. J Neurol 1994;241:592-596.
65. Leclerc A, Tomé FMS, Fardeau M. Ubiquitin and β-amyloid protein in inclusion body myositis (IBM), familial IBM-like disorder and oculopharyngeal muscular dystrophy; an immunocytochemical study. Neuromusc Disord 1993;3:283-291.
66. Lynch T, Sano M, Marder KS. et al. Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonsism-amyotrophic complex. Neurology 1994;44:1878-1884.
67. Beyenburg S, Zierz S. Chronic PEO and myalgia associated with tubular aggregates. Acta Neurol Scand 1993;87:397-402.
68. Moraes CT, Ciacci F, Bonilla E. et al. Two novel pathogenic mitochondrial DNA mutations affecting organelle number and protein synthesis. Is the tRNA (LeuUUR) gene an etiologic hot spot?. J Clin Invest 1993;92:2906-2915.
69. Siebel P, Flierl A, Kottlors M, Reichmann H. A rapid and sensitive PCR screening method for point mutations associated with mitochondrial encephalopathies. Biochem Biophys Res Commun 1994;200:938-942.
70. Rosenberg RN. Autosomal dominant cerebellar phenotypes; genotype has settled the issue. Neurology 1995;45:l-5.